UNSPSC 51452701: Praziquantel

This classification denotes an antihelminthic agent with the molecular formula C19H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6490C9U457, chemically known as 4h-pyrazino(2,1-a)isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- but generally known as praziquantel, which bears US NIH Compound Identifier 4891. European Medicines Agency schedules Praziquantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10008MIG.

UNSPSC 51452701 Praziquantel is a Commodity code nominally identifying a specific antiparasitic pharmaceutical, but recent state and local opportunities tagged to this code do not reflect praziquantel procurement; instead, they show purchasing of naloxone, drug deactivation systems, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing frameworks. The code's recent activity reflects state health agencies, county health departments, and municipalities buying pharmaceutical products, medical consumables, and emergency response supplies through formal competitive bidding (IFB), requests for proposal (RFP), and cooperative purchasing arrangements rather than single-product procurement.

Recent solicitations span Florida, Texas, and Minnesota-led cooperative purchasing. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county health building, on a two-year base plus one-year renewal term with FEMA potential funding. The City of Tampa's Purchasing Department issued IFB 26P00145 on March 25, 2026 for 169 line items of medical and first aid supplies (estimated contract value $700,000) for the Tampa Fire Department Rescue Division, designated as a sheltered small local business enterprise opportunity with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with awarded vendors required to partner with three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certification. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 as an exploratory market-intelligence tool regarding direct-to-manufacturer prescription programs for self-insured employee and retiree health plans. The mismatch between the code's nominal product scope and the breadth of pharmaceutical and medical-supply categories actually being procured suggests either systematic miscoding or use of this commodity code as a catch-all for pharmaceutical purchasing activity.